[1]胡传玺,刘灵燕,李 漫.血清白细胞介素-10、白细胞介素-17、白细胞介素-23检测对慢性阻塞性肺疾病合并侵袭性肺曲霉菌感染的诊断及预后评估价值[J].陕西医学杂志,2023,52(10):1415-1418.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.030]
　HU Chuanxi,LIU Lingyan,LI Man.Value of serum IL-10,IL-17 and IL-23 in the diagnosis and prognosis evaluation of COPD complicated with invasive pulmonary Aspergillus infection[J].,2023,52(10):1415-1418.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.030]
点击复制

血清白细胞介素-10、白细胞介素-17、白细胞介素-23检测对慢性阻塞性肺疾病合并侵袭性肺曲霉菌感染的诊断及预后评估价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1415-1418
栏目:
临床检验
出版日期:
2023-10-05

文章信息/Info

Title:
Value of serum IL-10,IL-17 and IL-23 in the diagnosis and prognosis evaluation of COPD complicated with invasive pulmonary Aspergillus infection
作者:
胡传玺; 刘灵燕; 李 漫
(上海交通大学医学院附属第九人民医院检验科,上海 201999)
Author(s):
HU Chuanxi; LIU Lingyan; LI Man
(Department of Clinical Laboratory,the Ninth People's Hospital Affiliated to School of Medicine of Shanghai Jiaotong University,Shanghai 201999,China)
关键词:
慢性阻塞性肺疾病;  白细胞介素-10;  白细胞介素-17;  白细胞介素-23;  诊断;  预后
Keywords:
Chronic obstructive pulmonary disease;  Interleukin-10;  Interleukin-17;  Interleukin-23;  Diagnosis;  Prognosis
分类号:
R 563.9
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.030
文献标志码:
A
摘要:
目的: 探讨血清白细胞介素-10(IL-10)、白细胞介素-17(IL-17)、白细胞介素-23(IL-23)对慢性阻塞性肺疾病(COPD)合并侵袭性肺曲霉菌(IPA)感染的诊断及预后评估价值。方法:选取90例COPD急性加重住院患者,筛查患者IPA感染情况,41例合并IPA感染的患者作为感染组,余49例作为无感染组,比较两组血清IL-10、IL-17、IL-23水平,分析其对IPA感染的诊断价值; 并统计感染组死亡情况,分析血清IL-10、IL-17、IL-23水平与预后的关系。结果: 感染组IL-10水平低于无感染组(P<0.05),IL-17、IL-23水平高于无感染组(均P<0.05); 血清IL-10、IL-17、IL-23及IL-10和IL-17联合、IL-10和IL-23联合、三项指标联合诊断COPD合并IPA感染ROC曲线下面积(AUC)分别为0.692、0.685、0.762、0.836、0.884、0.893,敏感度、特异度分别为66.45%、45.24%,70.50%、52.60%,78.05%、71.43%,60.98%、93.88%,87.80%、77.55%,90.24%、83.50%。41例COPD合并IPA感染患者中,6例死亡,死亡者血清IL-10明显低于存活者,血清IL-17、IL-23水平显著高于存活者(均P<0.05),但Cox回归分析显示仅IL-17为影响患者预后的独立因素(P<0.05)。结论: 对于COPD急性加重住院患者,合并IPA感染血清IL-10较低,IL-17、IL-23较高,其联合检测对于IPA感染的诊断及患者预后评估临床价值较高。
Abstract:
Objective:To investigate the value of serum interleukin(IL)-10,IL-17 and IL-23 in the diagnosis and prognosis evaluation of chronic obstructive pulmonary disease(COPD)with invasive pulmonary aspergillus(IPA)infection.Methods:Ninety hospitalized patients with acute exacerbation of COPD were selected.According to the status of IPA infection,the subjects were divided into infection group(41 patients with IPA infection)and non-infection group(the other 49 patients).Serum IL-10,IL-17 and IL-23 levels were compared between the two groups,and their diagnostic value for IPA infection was analyzed.The mortality of infection group was calculated,and the relationship between serum IL-10,IL-17 and IL-23 levels and the prognosis was analyzed.Results:Compared with the non-infection group,IL-10 level was lower,IL-17 and IL-23 levels were higher in the infection group(all P<0.05).The area under the ROC curve(AUC)values of serum IL-10,IL-17,IL-23,IL-10 combined with IL-17,IL-10 combined with IL-23,and combination of the three to diagnose COPD combined with IPA infection were 0.692,0.685,0.762,0.836,0.884 and 0.893,respectively.The sensitivity and specificity were 66.45% and 45.24%,70.50% and 52.60%,78.05% and 71.43%,60.98% and 93.88%,87.80% and 77.55%,90.24% and 83.50%,respectively.Among the 41 patients with COPD complicated with IPA infection,6 patients died.The dead had significantly lower serum IL-10 level and significantly higher serum IL-17 and IL-23 levels than the survivors(all P<0.05).However,Cox regression analysis showed that only IL-17 was an independent factor affecting the prognosis of patients(P<0.05).Conclusion:For patients with acute exacerbation of COPD,serum IL-10 level is lower,and IL-17 and IL-23 levels are higher in patients with IPA infection.Joint detection of these indicators can help to diagnose IPA infection and evaluate the prognosis.

参考文献/References:

[1] Ritchie AI,Wedzicha JA.Definition,causes,pathogenesis,and consequences of chronic obstructive pulmonary disease exacerbations[J].Clin Chest Med,2020,41(3):421-438.
[2] Brandsma CA,Vanden-Berge M,Hackett TL,et al.Recent advances in chronic obstructive pulmonary disease pathogenesis:From disease mechanisms to precision medicine[J].J Pathol,2020,250(5):624-635.
[3] Ma X,Wu Y,Zhang L,et al.Comparison and development of machine learning tools for the prediction of chronic obstructive pulmonary disease in the Chinese population[J].J Transl Mer,2020,18(1):146-150.
[4] 宋卫东,赵庆忠,蔡 波,等.益气活血化痰汤、无创双水平气道正压通气联合纳美芬治疗老年慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭疗效研究[J].陕西中医,2023,44(4):455-458.
[5] 杜锦辉,陈 芳.BiPAP无创呼吸机治疗慢性阻塞性肺疾病并Ⅱ型呼吸衰竭50例临床研究[J].陕西医学杂志,2020,49(7):824-826,865.
[6] Yagi K,Ushikubo M,Maeshima A,et al.Invasive pulmonary aspergillosis due to Aspergillus lentulus in an adult patient:A case report and literature review[J].J Infect Chemother,2019,25(7):547-551.
[7] Moura S,Cerqueira L,Almeida A.Invasive pulmonary aspergillosis:Current diagnostic methodologies and a new molecular approach[J].Eur J Clin Microbiol Infect Dis,2018,37(8):1393-1403.
[8] 高立静,安 阳,姜敏捷,等.血清烟曲霉IgG抗体联合支气管肺泡灌洗液半乳甘露聚糖检测对肺曲霉菌病的诊断价值[J].中华实验和临床感染病杂志:电子版,2020,14(2):104-109.
[9] 张 蕾,杨 青,赵 钊,等.慢性阻塞性肺疾病合并侵袭性肺曲霉病的临床特征及危险因素分析[J].中华临床感染病杂志,2020,13(2):113-118.
[10] Sun KS,Tsai CF,Chen SC,et al.Galactomannan testing and the incidence of invasive pulmonary aspergillosis:A 10-year nationwide population-based study in taiwan[J].PLoS One,2016,11(2):964-969.
[11] 王海英,陈 莉,王 允,等.环境因素对慢性阻塞性肺疾病患者的预后影响[J].公共卫生与预防医学,2023,34(3):83-87.
[12] 董秋月,高丛丛,刘才睿,等.山东省≥40岁人群慢性阻塞性肺疾病患病风险列线图预测模型建立[J].中国公共卫生,2023,39(5):604-611.
[13] Moldoveanu B,Gearhart AM,Jalil BA,et al.Pulmonary aspergillosis:Spectrum of disease[J].Am J Med Sci,2021,361(4):411-419.
[14] Bao Z,Chen H,Zhou M,et al.Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease:A case report and review of the literature[J].Oncotarget,2017,8(23):38069-38074.
[15] 吴钟辉,张运涛,冯 玉.老年慢性阻塞性肺疾病患者合并侵袭性肺曲霉菌病的危险因素[J].中国老年学杂志,2020,40(7):1433-1436.
[16] 李小四,冯 燕,钱 宁,等.慢性阻塞性肺疾病急性加重期合并肺曲霉菌感染的危险因素分析[J].中国消毒学杂志,2020,37(10):774-777.
[17] Nagata K,Nishiyama C.IL-10 in mast cell-mediated immune responses:Anti-inflammatory and proinflammatory roles[J].Int J Mol Sci,2021,22(9):4972-4975.
[18] 阮国虎,李 欢.IL-10与慢性阻塞性肺疾病严重程度的关系[J].临床肺科杂志,2019,24(4):669-672.
[19] 何 燚,伍晓玲,陈晓婷.白细胞介素-17在慢性阻塞性肺疾病患者中的表达及作用机制[J].免疫学杂志,2019,35(4):341-347,355.
[20] 陈择岐,余万辉,谢燕梅,等.慢性阻塞性肺疾病合并侵袭性肺曲霉病患者血清 IL-12、IL-15、IL-17水平变化及意义[J].山东医药,2015,55(4):53-54.
[21] 黄振杰,曾彤华,蔡文华,等.慢阻肺患者血清白介素-17、白介素-23及和肽素的变化及意义[J].临床肺科杂志,2016,21(2):203-205,209.

相似文献/References:

[1]马明铭,李 芳,杨 慧,等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响[J].陕西医学杂志,2019,(4):515.
　MA Mingming,LI Fang,YANG Hui,et al.Effect of tiotropium bromide powder and nonpharmacological rehabilitation program on BODE index in patients with chronic obstructive pulmonary disease[J].,2019,(10):515.
[2]朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期〖JZ〗伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,(10):1353.
　ZHU Xiaochuan..Clinical value of platelet/lymphocyte ratio in predicting early renal impairment〖JZ〗 in acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(10):1353.
[3]张军营.吸烟对慢阻肺患者血清S100A8/A9、8异前列腺素F2α、组织蛋白酶S及其它炎症因子表达水平的影响*[J].陕西医学杂志,2019,(11):1426.
[4]焦文妤,尚家璐,李树霞△.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,(12):1616.
[5]陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102.
[6]薛佩妮,冯敏娟△,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响*[J].陕西医学杂志,2020,49(2):216.
　XUE Peini,FENG Minjuan,WANG Huiqin..Efficacy of tiotropium bromide combined with glucocorticoids in the treatment of COPD and its effect on patients' quality of life score[J].,2020,49(10):216.
[7]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
　WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(10):1510.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
[8]焦文妤,高爱华△.血清可溶性髓系细胞触发受体-1与临床肺部感染评分在慢性阻塞性肺疾病呼吸机相关性肺炎早期诊断及预后判断中的效能研究[J].陕西医学杂志,2020,49(12):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
　JIAO Wenyu,GAO Aihua..Effectiveness of sTREM-1 and CPIS in early diagnosis and prognosis judgment of ventilator-associated pneumonia in COPD[J].,2020,49(10):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
[9]张卓红,赵拖利.慢性阻塞性肺疾病大鼠血液、支气管灌洗液中水通道蛋白及p-c-Jun-N-末端激酶表达情况实验研究[J].陕西医学杂志,2021,50(7):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
　ZHANG Zhuohong,ZHAO Tuoli.Expression of AQP-1 and p-JNK in blood and bronchial lavage fluid of rats with COPD[J].,2021,50(10):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
[10]余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]
　YU Gang,ZHANG Sixue.The levels of INF-γ and YKL-40 in patients with AECOPD and their correlation with prognosis and lung function[J].,2021,50(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]

备注/Memo

备注/Memo:
基金项目:上海市科学技术计划项目(174119678)
更新日期/Last Update: 2023-10-07